VIVE Insider Trading Activity and SEC Form 4 Filings
VIVE insider trading summary
No open-market insider purchases or sales of Viveve Medical, Inc. (VIVE) have been reported on SEC Form 4 in the past 12 months.
Latest VIVE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 1, 2019 | Goldman Sachs & Co. LLC | Insider | Sell | $132K (23,688 @ $5.56) |
| Oct 1, 2019 | Goldman Sachs Group Inc | Insider | Sell | $132K (23,688 @ $5.56) |
| Sep 30, 2019 | Goldman Sachs Group Inc | Insider | Sell | $313K (68,737 @ $4.55) |
| Sep 30, 2019 | Goldman Sachs & Co. LLC | Insider | Sell | $313K (68,737 @ $4.55) |
| Sep 27, 2019 | Goldman Sachs & Co. LLC | Insider | Sell | $27K (5,359 @ $5.02) |
| Sep 27, 2019 | Goldman Sachs Group Inc | Insider | Sell | $27K (5,359 @ $5.02) |
| Sep 26, 2019 | Goldman Sachs Group Inc | Insider | Sell | $37K (7,001 @ $5.25) |
| Sep 26, 2019 | Goldman Sachs & Co. LLC | Insider | Sell | $37K (7,001 @ $5.25) |
| Sep 25, 2019 | Goldman Sachs & Co. LLC | Insider | Sell | $61K (10,799 @ $5.63) |
| Sep 25, 2019 | Goldman Sachs Group Inc | Insider | Sell | $61K (10,799 @ $5.63) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.